Waterland Completes €3.8B Sale of Omega Pharma to Perrigo
April 01, 2015
Waterland Private Equity Investments has sold portfolio company Omega Pharma Invest to Perrigo Company (NYSE: PRGO) in a cash-and-equity transaction valued at approximately €3.8 billion; the deal includes the assumption of €1.3 billion in debt. Omega, which generated about €1.27 billion in 2014 revenues, markets over-the-counter health and personal care products. Waterland took the company private in 2012 via its Fund V, which closed in 2011 with €1.1 billion in commitments and had generated an IRR of 38.16% as of December 31.